Related Experiment Video
Updated: Jan 29, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Sarcopenia Predicts Mortality in Bladder Cancer with Neoadjuvant Chemotherapy: A Multicenter Study
Alice Pitout1, Charles Mazeaud1,2, Alicia Blondeau1
1Department of Urology, CHRU de Nancy, 54500 Vandoeuvre -lès-Nancy, France.
Sarcopenia, a measure of muscle mass, is a significant predictor of mortality in bladder cancer patients undergoing neoadjuvant chemotherapy. This study highlights its prognostic value and compares different measurement thresholds for improved clinical assessment.
Area of Science:
- Oncology
- Radiology
- Geriatrics
Background:
- Sarcopenia, assessed via CT scans, is a known negative prognostic factor in various cancers.
- Its role in bladder cancer patients receiving neoadjuvant chemotherapy is not well-established.
- This research investigates sarcopenia's prognostic impact on survival outcomes in this specific patient group.
Purpose of the Study:
- To evaluate the prognostic significance of sarcopenia on survival in bladder cancer patients.
- To compare different sarcopenia measurement thresholds and their impact on prognostic accuracy.
- To assess sarcopenia's association with progression-free survival (PFS) and pathological complete response (pCR).
Main Methods:
- Retrospective multicenter study of 74 invasive urothelial carcinoma patients treated with neoadjuvant chemotherapy and cystectomy (2015-2021).
- Sarcopenia assessed using Skeletal Muscle Index on CT scans before chemotherapy (BC) and before surgery (BS).
- Primary endpoint: overall survival. Secondary endpoints: PFS, pCR, treatment complications.
Main Results:
- Sarcopenia prevalence was 27% BC and 39% BS.
- Sarcopenia was significantly associated with increased all-cause mortality (HR 3.38-6.08, p=0.012-0.032) and shorter PFS.
- Forty percent achieved pCR, 35% had recurrence; median PFS was 25 months.
Conclusions:
- Sarcopenia is an independent and reproducible prognostic factor for mortality in bladder cancer patients.
- The study provides the first comparison of sarcopenia threshold values at different time points (BC vs. BS).
- Findings suggest incorporating sarcopenia assessment into clinical practice for risk stratification.
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Predicting Molecular Geometry
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...

